PNPLA3 and hepatocellular carcinoma: Therefore, given the independent association of the PNPLA3 I148M variant with fibrosis progression and hepatocellular carcinoma risk [24], PNPLA3 I148M genotyping may help refining treatment prioritization to novel therapeutic regimens based on direct antiviral agents [37], and patients follow-up.